LAKE FOREST, Calif.-- I-Flow Corporation announced today the launch of the new ON-Q Elite Pain Relief System, an extension of its market leading ON-Q Post-Operative Pain Relief product line.
"ON-Q Elite was specifically designed to meet the need for a simple, reusable pump that provides post-operative pain relief for surgeries performed in outpatient surgery centers," says Donald M. Earhart, I-Flow's chairman, president and CEO. "ON-Q Elite can utilize existing reimbursement codes where pain management is a covered benefit requiring the use of durable medical equipment. This cost-effective and easy to use infusion pump incorporates our patented technologies to deliver non-narcotic medication to patients in a previously underserved and growing market. ON-Q Elite will be marketed through our InfuSystem operating unit, where we expect to benefit from InfuSystem's provider contracts covering more than 120 million potential patients and use its medical insurance billing expertise to maximize the product's reimbursement opportunities. The InfuSystem business model allows us to provide a unique offering designed specifically for outpatient surgery centers."
"By including ON-Q Elite in their new standard of care, surgeons will enable patients to get back to their normal lives faster," Earhart continued. "Clearly, the introduction of ON-Q Elite strengthens our position as the emerging standard of care for post-surgical pain treatment.
The ON-Q Elite Pain Relief System is designed to infuse a local anesthetic directly to a surgical site over multiple days following a variety of surgeries, including orthopedic procedures and hernia repair.
I-Flow Corporation designs, develops and markets technically advanced drug-delivery systems that are redefining the standard of care by providing life enhancing, cost effective solutions for pain management and infusion therapy.
Source: I-Flow Corporation
Beyond the Surface: Tackling the Sterilization Challenges of Flexible Endoscopes
May 26th 2025Flexible endoscopes revolutionized modern medicine—but their complex design poses persistent sterilization challenges. With mounting infection risks and emerging innovations, experts are rethinking how to clean and safeguard one of health care’s most indispensable tools.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.